Merck pigments could thwart drug fakers
German pharmaceutical and chemicals supplier Merck KGaA has set up a new business unit to try and establish how some of the company's pigments can be used as brand protection technologies.
Archives for May 19, 2004
New obesity target licensed to CytRx
Imperial College London in the UK has licensed rights to a drug target with potential in obesity to US company CytRx.
Plant metabolism steered to drug synthesis
Researchers in Finland and Belgium have developed a new way of making plant-derived compounds in cell cultures that should cut the cost of manufacturing a raft of pharmaceuticals, including drugs for cancer.
SkyePharma lifted by US approval
UK drug delivery specialist SkyePharma received another welcome boost yesterday with the news that its new formulation of morphine had been approved in the US.
UK start-up offers leading edge chemistry
A new company has been set up in the UK to apply high-throughput technologies to the development of new chemical materials, including catalysts and novel drugs, for use in the pharmachem industries.
Banner tackles Japanese market
Banner Pharmacaps has entered into an agreement to introduce its non-animal-derived softgel capsules in Japan for pharmaceutical and nutritional applications.
Roche claiming victory in PCR dispute
After over a decade of litigation, Roche Molecular Systems has won a 'significant legal victory' in a US court case challenging the validity of patents on its polymerase chain reaction technology, according to the attorney representing the company in...